Literature DB >> 15113995

HLA-B60 and B61 are strongly associated with ankylosing spondylitis in HLA-B27-negative Taiwan Chinese patients.

J C C Wei1, W C Tsai, H S Lin, C Y Tsai, C T Chou.   

Abstract

OBJECTIVES: Carriage of HLA-B60 has been shown to increase the risk of ankylosing spondylitis (AS) in B27-positive Caucasian patients, but the association in B27-negative cases is less certain. This study assessed HLA class I gene associations in Chinese HLA-B27-negative AS patients.
METHODS: Forty-one Chinese HLA-B27-negative AS patients fulfilling the modified New York diagnostic criteria for AS were recruited, and 11 383 HLA-B27-negative blood donors were used for comparison. HLA-A and -B typing was done with the microlymphocytotoxicity assay.
RESULTS: Among the B27-negative AS patients, 21 were male and 20 were female. Of HLA-B alleles, only B60 and B61 significantly increased susceptibility to AS in HLA-B27-negative patients (P<0.001).
CONCLUSIONS: In Taiwan Chinese, carriage of B60 is increased in HLA-B27-negative AS patients. The association between B61 and HLA-B27-negative AS patients has not been reported previously. Whether the gene involved is HLA-B60 or B61 or another gene in linkage disequilibrium with these genes is unknown.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15113995     DOI: 10.1093/rheumatology/keh193

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  32 in total

1.  Screening and evaluating the mimic peptides as a useful serum biomarker of ankylosing spondylitis using a phage display technique.

Authors:  Min Wang; Xianping Li; Jingwei Chen; Yong Zhou; Hong Cao; Xiang Wu; Hongmin Jiang
Journal:  Rheumatol Int       Date:  2010-03-19       Impact factor: 2.631

Review 2.  Ankylosing spondylitis: A state of the art factual backbone.

Authors:  Mohammad Ghasemi-Rad; Hosam Attaya; Emal Lesha; Andrea Vegh; Tooraj Maleki-Miandoab; Emad Nosair; Nariman Sepehrvand; Ali Davarian; Hamid Rajebi; Abdolghader Pakniat; Seyed Amirhossein Fazeli; Afshin Mohammadi
Journal:  World J Radiol       Date:  2015-09-28

Review 3.  Polymorphism of HLA-B27: 105 subtypes currently known.

Authors:  Muhammad Asim Khan
Journal:  Curr Rheumatol Rep       Date:  2013-10       Impact factor: 4.592

4.  Association of tumour necrosis factor alpha promoter polymorphisms with ankylosing spondylitis in Taiwan.

Authors:  Ming-Yuh Shiau; Mei-Kuei Lo; Cheng-Pei Chang; Tzi-Peng Yang; Kuo-Ting Ho; Yih-Hsin Chang
Journal:  Ann Rheum Dis       Date:  2007-04       Impact factor: 19.103

Review 5.  Revisiting MHC genes in spondyloarthritis.

Authors:  Maxime Breban; Félicie Costantino; Claudine André; Gilles Chiocchia; Henri-Jean Garchon
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

Review 6.  Recent studies on the genetic basis of ankylosing spondylitis.

Authors:  John D Reveille
Journal:  Curr Rheumatol Rep       Date:  2009-10       Impact factor: 4.592

Review 7.  An update on the contribution of the MHC to AS susceptibility.

Authors:  John D Reveille
Journal:  Clin Rheumatol       Date:  2014-05-18       Impact factor: 2.980

8.  Two cases of SAPHO syndrome accompanied by classic features of Behcet's disease and review of the literature.

Authors:  Hiroki Yabe; Yoji Takano; Eiki Nomura; Masanori Nakayama; Michiya Kihara; Shun-Ichi Miyakawa; Yukio Horiuchi
Journal:  Clin Rheumatol       Date:  2007-08-24       Impact factor: 2.980

9.  Mucosal lesions may be a minor complication of SAPHO syndrome: a study of 11 Japanese patients with SAPHO syndrome.

Authors:  Hiroki Yabe; Hisaji Ohshima; Yoji Takano; Takahiro Koyanagi; Hiroshi Usui; Kenya Nojiri; Kensuke Ochi; Michiya Kihara; Yukio Horiuchi
Journal:  Rheumatol Int       Date:  2009-09-23       Impact factor: 2.631

Review 10.  Progress in spondylarthritis. Progress in studies of the genetics of ankylosing spondylitis.

Authors:  Matthew A Brown
Journal:  Arthritis Res Ther       Date:  2009-10-29       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.